Thus, further characterization of the synergy between IFNγ and Gal-9 during the induction of Ido1 and Ido2 is important to our understanding the pathophysiology of autoimmune disorders such as MS, Hashimoto’s disease, or rheumatoid arthritis. This evidence concerns the gene IDO1 and myeloid sarcoma.